BEBIG Medical — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

BEBIG Medical is a well-established, privately-held global provider of radiation oncology devices, with a strong commercial footprint of over 1,000 active installations worldwide. The company's business model is centered on the manufacturing and sale of physical medical device systems for external beam and brachytherapy, positioning it firmly in the 'Commercial' stage as a revenue-generating entity. Its strategic focus is on delivering affordable, robust radiation therapy technology to a broad global market, supported by offices and teams in Europe, the US, and Asia. While not a biopharmaceutical developer, it is a key player in the radiopharmaceuticals/radiation therapy equipment sector.

Oncology

Technology Platform

Integrated suite of radiation therapy delivery devices including HDR brachytherapy afterloaders & treatment planning systems, linear accelerators, intraoperative radiation therapy (IORT) devices, and X-ray therapy systems for superficial treatments.

Opportunities

Growing global cancer incidence and demand for cost-effective radiotherapy solutions in emerging markets present significant expansion opportunities.

The company's focus on affordability and its established distributor network position it well to capture market share in cost-sensitive regions.

Additionally, the clinical adoption of brachytherapy and intraoperative radiation therapy (IORT) for specific cancer types offers avenues for focused growth within its core specialties.

Risk Factors

Intense competition from larger, better-funded medical device conglomerates poses a constant threat to market share.

The company also faces significant regulatory risks associated with maintaining certifications across multiple global markets under evolving regulations like the EU MDR.

Technological disruption from advanced modalities (e.g., MR-LINAC, proton therapy) could render its current portfolio less competitive if innovation is not sustained.

Competitive Landscape

BEBIG Medical operates in a highly competitive market dominated by giants like Varian (Siemens Healthineers) and Elekta, which offer comprehensive oncology suites. It differentiates itself through a value-based proposition of robust, affordable technology and a focused portfolio in brachytherapy and IORT. It also competes with other specialized players in brachytherapy (e.g., Eckert & Ziegler BEBIG) and superficial/orthovoltage therapy.

More companies in Radiopharmaceuticals →More companies in Germany →